Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 2
1967 2
1968 7
1969 7
1970 4
1971 6
1972 7
1973 16
1974 6
1975 9
1976 12
1977 9
1978 19
1979 20
1980 32
1981 20
1982 22
1983 30
1984 40
1985 45
1986 53
1987 44
1988 39
1989 52
1990 47
1991 54
1992 48
1993 57
1994 61
1995 59
1996 54
1997 47
1998 27
1999 43
2000 29
2001 23
2002 35
2003 25
2004 22
2005 29
2006 19
2007 26
2008 24
2009 24
2010 29
2011 23
2012 21
2013 21
2014 21
2015 22
2016 16
2017 17
2018 17
2019 13
2020 21
2021 22
2022 9
2023 13
2024 15
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,482 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
Friedman BW, Solorzano C, Kessler BD, Martorello K, Lutz CL, Feliciano C, Adler N, Moss H, Cain D, Irizarry E. Friedman BW, et al. Neurology. 2023 Oct 3;101(14):e1448-e1454. doi: 10.1212/WNL.0000000000207648. Epub 2023 Aug 21. Neurology. 2023. PMID: 37604662 Free PMC article. Clinical Trial.
Thirty-five of 102 (34%) participants in the metoclopramide +4 mg arm achieved sustained headache relief as did 42/102 (41%) participants in the metoclopramide +16 mg arm (absolute difference 7%, 95% CI -6% to 20%). ...DISCUSSION: When added to 10 mg IV metoclopr …
Thirty-five of 102 (34%) participants in the metoclopramide +4 mg arm achieved sustained headache relief as did 42/102 (41%) particip …
The Efficacy of Metoclopramide for Gastric Visualization by Endoscopy in Patients With Active Upper Gastrointestinal Bleeding: Double-Blind Randomized Controlled Trial.
Vimonsuntirungsri T, Thungsuk R, Nopjaroonsri P, Faknak N, Pittayanon R. Vimonsuntirungsri T, et al. Am J Gastroenterol. 2024 May 1;119(5):846-855. doi: 10.14309/ajg.0000000000002620. Epub 2023 Dec 7. Am J Gastroenterol. 2024. PMID: 38059896 Clinical Trial.
RESULTS: Of the 68 eligible patients, 3 of each group were excluded by protocol violation. Finally, 62 patients (31 metoclopramide and 31 placebo) were analyzed. The percentage of patients with adequate visualization in metoclopramide and placebo group was 77.4% and …
RESULTS: Of the 68 eligible patients, 3 of each group were excluded by protocol violation. Finally, 62 patients (31 metoclopramide an …
Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants.
Montealegre-Pomar ADP, Charpak N. Montealegre-Pomar ADP, et al. Paediatr Drugs. 2021 Nov;23(6):591-599. doi: 10.1007/s40272-021-00475-x. Epub 2021 Oct 25. Paediatr Drugs. 2021. PMID: 34693501 Clinical Trial.
AIM: Because of the recent controversy on the use of metoclopramide in children, this study was conducted to evaluate the effectiveness and safety of metoclopramide given as GER disease (GERD) prophylaxis. ...CONCLUSION: Results show absence of effectiveness in the …
AIM: Because of the recent controversy on the use of metoclopramide in children, this study was conducted to evaluate the effectivene …
Metoclopramide: a review of its pharmacological properties and clinical use.
Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS. Pinder RM, et al. Drugs. 1976;12(2):81-131. doi: 10.2165/00003495-197612020-00001. Drugs. 1976. PMID: 786607 Review.
Metoclopramide, 4-amino-5-chloro-2-methoxy-N-(2-diethyl-aminoethyl) benzamide, is advocated for use in gastro-intestinal diagnostics, and in treating various types of vomiting and a variety of functional and organic gastro-intestinal disorders. ...Metoclopramide red …
Metoclopramide, 4-amino-5-chloro-2-methoxy-N-(2-diethyl-aminoethyl) benzamide, is advocated for use in gastro-intestinal diagnostics, …
Comparison of the Effects of Govarcin Herbal Capsule and Metoclopramide for Alleviating Gastrointestinal Symptoms in Patients with Functional Dyspepsia: A Randomized Double-blind Clinical Trial.
Asghari M, Ahmadpour S, Molazadeh M, Jafari MM, Hormati A, Pashaei MR, Mohammadpour Y, Habibi MA, Mohammadbeigi A, Hoseini SME. Asghari M, et al. Rev Recent Clin Trials. 2024;19(2):143-149. doi: 10.2174/0115748871266848231120112355. Rev Recent Clin Trials. 2024. PMID: 38099534 Clinical Trial.
The participants had FD and were divided into two groups receiving Govarcin and Metoclopramide by block randomization. The patients were treated for four weeks, taking one Govarcin capsule or Metoclopramide tablet after each meal. ...Nepean score in Govarcin group b …
The participants had FD and were divided into two groups receiving Govarcin and Metoclopramide by block randomization. The patients w …
A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults.
Barrett TW, DiPersio DM, Jenkins CA, Jack M, McCoin NS, Storrow AB, Singleton LM, Lee P, Zhou C, Slovis CM. Barrett TW, et al. Am J Emerg Med. 2011 Mar;29(3):247-55. doi: 10.1016/j.ajem.2009.09.028. Epub 2010 Mar 26. Am J Emerg Med. 2011. PMID: 20825792 Clinical Trial.
Patients with a minimum preenrollment VAS of 40 mm were randomized to intravenous ondansetron 4 mg, metoclopramide 10 mg, promethazine 12.5 mg, or saline placebo. A 12-mm VAS improvement in nausea severity was deemed clinically important. ...The median 30-minute VAS differ …
Patients with a minimum preenrollment VAS of 40 mm were randomized to intravenous ondansetron 4 mg, metoclopramide 10 mg, promethazin …
Metoclopramide as intermittent and continuous infusions in critically ill patients: a pilot randomized clinical trial.
Malekolkottab M, Khalili H, Mohammadi M, Ramezani M, Nourian A. Malekolkottab M, et al. J Comp Eff Res. 2017 Mar;6(2):127-136. doi: 10.2217/cer-2016-0067. Epub 2017 Jan 24. J Comp Eff Res. 2017. PMID: 28114798 Free article. Clinical Trial.
AIM: Metoclopramide is commonly used as a prokinetic agent in critically ill patients with enteral feeding intolerance. ...METHODS: Forty critically ill adults patients were assigned to receive metoclopramide as either intermittent (10 mg every 6 h) or continuous (2 …
AIM: Metoclopramide is commonly used as a prokinetic agent in critically ill patients with enteral feeding intolerance. ...METHODS: F …
Metoclopramide role in preventing ileus after cesarean, a clinical trial.
Agah J, Baghani R, Rakhshani MH, Rad A. Agah J, et al. Eur J Clin Pharmacol. 2015 Jun;71(6):657-662. doi: 10.1007/s00228-015-1845-8. Epub 2015 Apr 15. Eur J Clin Pharmacol. 2015. PMID: 25877021 Clinical Trial.

RESULTS: The interval between cesarean and the first flatus (p < 0.0001), defecation (p < 0.0001), feeling of hunger (p < 0.0001), feeding (p = 0.007), and ambulation (p < 0.0001) were significantly shorter in the metoclopramide group. In addition, polytomous l

…

RESULTS: The interval between cesarean and the first flatus (p < 0.0001), defecation (p < 0.0001), feeling of hunger (p < 0.0001),

…
Metoclopramide for acute migraine: a dose-finding randomized clinical trial.
Friedman BW, Mulvey L, Esses D, Solorzano C, Paternoster J, Lipton RB, Gallagher EJ. Friedman BW, et al. Ann Emerg Med. 2011 May;57(5):475-82.e1. doi: 10.1016/j.annemergmed.2010.11.023. Epub 2011 Jan 12. Ann Emerg Med. 2011. PMID: 21227540 Free PMC article. Clinical Trial.
STUDY OBJECTIVE: Intravenous metoclopramide is effective as primary therapy for acute migraine, but the optimal dose of this medication is not yet known. ...CONCLUSION: Twenty milligrams or 40 mg of metoclopramide is no better for acute migraine than 10 mg of met …
STUDY OBJECTIVE: Intravenous metoclopramide is effective as primary therapy for acute migraine, but the optimal dose of this medicati …
Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial.
Warusevitane A, Karunatilake D, Sim J, Lally F, Roffe C. Warusevitane A, et al. Stroke. 2015 Feb;46(2):454-60. doi: 10.1161/STROKEAHA.114.006639. Epub 2014 Dec 16. Stroke. 2015. PMID: 25516196 Clinical Trial.
There were significantly more episodes of pneumonia in the placebo group than in the metoclopramide group (rate ratio, 5.24; P<0.001). There were also significant differences in favor of metoclopramide in the rate of aspiration, oxygen saturation, highest inflamm …
There were significantly more episodes of pneumonia in the placebo group than in the metoclopramide group (rate ratio, 5.24; P<0.0 …
1,482 results